These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 39239010)

  • 61. Rhino-orbito-cerebral mucormycosis (ROCM) with internal carotid artery stenosis in a diabetic patient with caries tooth and oroantral fistula.
    Manjunath KS; Shivaswamy S; Kulkarni JD; Kenkare Venkatachalaiah R
    BJR Case Rep; 2016; 2(2):20150447. PubMed ID: 30363653
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans.
    Liang KP; Tleyjeh IM; Wilson WR; Roberts GD; Temesgen Z
    J Clin Microbiol; 2006 Mar; 44(3):892-8. PubMed ID: 16517873
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.
    Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P
    Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rhino-orbital and rhino-orbito-cerebral mucormycosis.
    Talmi YP; Goldschmied-Reouven A; Bakon M; Barshack I; Wolf M; Horowitz Z; Berkowicz M; Keller N; Kronenberg J
    Otolaryngol Head Neck Surg; 2002 Jul; 127(1):22-31. PubMed ID: 12161726
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mucormycosis in post-covid patients: An epidemic in pandemic.
    Kesarwani V; Kumar A; Kesarwaani S; Kesarwani D
    J Family Med Prim Care; 2022 Jun; 11(6):3368-3371. PubMed ID: 36119254
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Study of Profile of Mucormycosis During the Second Wave of COVID-19 in a Tertiary Care Hospital.
    Kamath S; Kumar M; Sarkar N; Ahmed T; Sunder A
    Cureus; 2022 Jan; 14(1):e21054. PubMed ID: 35155019
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
    Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
    Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
    [TBL] [Abstract][Full Text] [Related]  

  • 68. COVID-19 associated rhino-orbital-cerebral mucormycosis-an institutional series.
    Naruka S; Rana N; Singh N; Kishore A; Nagpal K
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):134S-144S. PubMed ID: 35176884
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rhino-orbital mucormycosis due to Apophysomyces ossiformis in a patient with diabetes mellitus: a case report.
    Martínez-Herrera E; Frías-De-León MG; Julián-Castrejón A; Cruz-Benítez L; Xicohtencatl-Cortes J; Hernández-Castro R
    BMC Infect Dis; 2020 Aug; 20(1):614. PubMed ID: 32811466
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A study of rhino-orbito-cerebral mucormycosis with COVID-19: A new challenge in North West of Rajasthan.
    Kumar S; Kumar H; Mali M; Meena BL
    Ann Afr Med; 2022; 21(4):383-389. PubMed ID: 36412339
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Adjunctive treatment with hyperbaric oxygen in a patient with rhino-sinuso-orbital mucormycosis].
    Melero M; Kaimen Maciel I; Tiraboschi N; Botargues M; Radisic M
    Medicina (B Aires); 1991; 51(1):53-5. PubMed ID: 1921693
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A rare presentation of rhino-orbital-cutaneous mucormycosis in an immunocompetent patient: a case report.
    Dhiyantari NPAR; Lutfi D; Susilo DH; Kristyono I; Widya A
    Pan Afr Med J; 2024; 48():13. PubMed ID: 39184848
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study.
    Cag Y; Erdem H; Gunduz M; Komur S; Ankarali H; Ural S; Tasbakan M; Tattevin P; Tombak A; Ozturk-Engin D; Tartar AS; Batirel A; Tekin R; Duygu F; Caskurlu H; Kurtaran B; Durdu B; Haciseyitoglu D; Rello J;
    Eur J Intern Med; 2022 Jun; 100():56-61. PubMed ID: 35304041
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rhino-Orbital Cerebral Mucormycosis in a Patient With Diabetic Ketoacidosis: A Case Report and Literature Review.
    Dong N; Jordan AE; Shen X; Wu X; Guo X; Zhao H; Wang Y; Wang D; Fang Q
    Front Neurol; 2022; 13():815902. PubMed ID: 35599740
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review.
    Karkhur S; Soni D; Chauhan K; Sarkar D; Gautam M; Verma S; Nyodu R; Yadav N; Sharma B
    Indian J Ophthalmol; 2023 Jan; 71(1):39-56. PubMed ID: 36588206
    [TBL] [Abstract][Full Text] [Related]  

  • 76. More than meets the eye: rhino-orbital cerebral mucormycosis with diabetic ketoacidosis presenting as periorbital edema resulting in orbital exenteration and maxillectomy.
    Nashawi M; Singh I; Ashai D; Abbasi J; Sathyamoorthy M
    Proc (Bayl Univ Med Cent); 2024; 37(2):348-354. PubMed ID: 38343486
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rhino-orbital-cerebral mucormycosis caused by
    Li J; Ge Y; Xin C; Jiang L
    Front Cell Infect Microbiol; 2024; 14():1375058. PubMed ID: 39081868
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rhino-Orbital Mucormycosis in a COVID-19 Patient: A Dreadful Challenge.
    Dhakal A; Pokharel M; Madhup S; Khadka L; Sapkota B
    Kathmandu Univ Med J (KUMJ); 2022; 20(78):249-251. PubMed ID: 37017177
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Rhinocerebral mucormycosis due to Rhizopus oryzae in a diabetic patient: a case report.
    Erami M; Shams-Ghahfarokhi M; Jahanshiri Z; Sharif A; Razzaghi-Abyaneh M
    J Mycol Med; 2013 Jun; 23(2):123-9. PubMed ID: 23721995
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Post-COVID-19 rhino-orbito-cerebral mucormycosis: a new addition to challenges in pandemic control.
    Mitra S; Janweja M; Sengupta A
    Eur Arch Otorhinolaryngol; 2022 May; 279(5):2417-2422. PubMed ID: 34309754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.